PET quantification method can help improve amyloid pathology assessment

Utilizing non-displaceable binding potential (BPND) quantification with 18F-Flutemetamol PET imaging can better assess amyloid pathology in elderly patients with low amyloid buildup compared to traditional standard uptake value ratio (SUVr), reported authors of an Oct. 12 study in the Journal of Nuclear Medicine. {read more here}

Tau positron emission tomography (PET) provides the most consistent predictive value for cognitive decline in cognitively normal and cognitively impaired adults compared with other commonly used biomarkers, according to a study published in Neurology. {read more here}

A dedicated breast PET scanner fell short in a European research study assessing its value for detecting cancer in women with suspicious mammograms. Spanish researchers found the system missed nine of 18 cancers in a small group of 50 women, according to an October 3 study in the European Journal of Radiology.  {read more here}

The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health, has published a new plan for tuberculosis research, and imaging — particularly PET/CT — is a key part of the strategy. {read more here}